Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
Department of Biology, Faculty of Science, Eskisehir Technical University, Eskişehir, Turkey.
Hum Exp Toxicol. 2019 Dec;38(12):1384-1396. doi: 10.1177/0960327119871094. Epub 2019 Sep 2.
Zonisamide (ZNS) is an anticonvulsant which is used to treat the symptoms of epilepsy. Although it is frequently used during reproductive ages, studies that investigated the effects of ZNS on reproductive system are limited. Therefore, we aimed to assess the effects of ZNS on male reproductive system by oral administration to rats in 25, 50, and 100 mg/kg doses for 28 days. After the exposure period, sperm concentration, motility, morphology, and DNA damage, as biomarkers of reproductive toxic effects, were determined, and histopathological examination of testis was performed. In addition, levels of the hormones that play a role in the regulation of reproductive functions, such as follicle-stimulating hormone, luteinizing hormone (LH), and testosterone were measured and the levels of oxidative stress biomarkers that take part in the reproductive pathologies such as catalase, superoxide dismutase, glutathione, and malondialdehyde, were determined. Reproductive toxic effects related to ZNS administration were shown by the significant decrease of sperm concentration and normal sperm morphology in ZNS groups. Additionally, pathological findings were observed in the testicular tissues of ZNS-administered groups dose dependently. In addition, serum LH and testosterone levels were significantly decreased in the ZNS groups. Decreased catalase activities and increased malondialdehyde levels in ZNS groups were evaluated as oxidative stress findings in the testis tissue. It could be expressed that ZNS administration induced dose-dependent reproductive toxic effects in rats, and pathological findings associated with the reproductive system could be the result of that hormonal changes and testicular oxidative stress, which in turn might be considered as possible mechanisms of male reproductive toxicity.
唑尼沙胺(ZNS)是一种抗癫痫药,用于治疗癫痫症状。尽管它在生殖年龄段经常使用,但研究 ZNS 对生殖系统影响的研究有限。因此,我们旨在通过口服给药,以 25、50 和 100mg/kg 剂量连续 28 天,评估 ZNS 对雄性生殖系统的影响。暴露期结束后,测定精子浓度、活力、形态和 DNA 损伤作为生殖毒性效应的生物标志物,并进行睾丸组织病理学检查。此外,还测定了调节生殖功能的激素(如促卵泡激素、黄体生成素(LH)和睾酮)水平,以及参与生殖病理的氧化应激生物标志物(如过氧化氢酶、超氧化物歧化酶、谷胱甘肽和丙二醛)水平。ZNS 给药引起的生殖毒性效应表现为精子浓度显著降低和正常精子形态减少。此外,ZNS 给药组的睾丸组织出现了剂量依赖性的病理发现。此外,ZNS 组的血清 LH 和睾酮水平显著降低。ZNS 组的过氧化氢酶活性降低和丙二醛水平升高被评估为睾丸组织的氧化应激发现。可以说,ZNS 给药在大鼠中引起了剂量依赖性的生殖毒性效应,与生殖系统相关的病理发现可能是激素变化和睾丸氧化应激的结果,而这反过来又可能被认为是雄性生殖毒性的可能机制。